ABSTRACT. The anticancer anthracyclines doxorubicin and daunorubicin are used to treat a variety of cancers in dogs. The therapeutic utility of anthracyclines is limited by cardiotoxicity in some cases. Synthesis of anthracycline alcohol metabolites by carbonyl reductase 1 (CBR1) is crucial for the pathogenesis of cardiotoxicity. We hypothesize that genetic polymorphisms in canine cbr1 contribute to the variable pharmacodynamics of anthracyclines in dogs. DNA sequence variants in canine cbr1 were investigated in DNA samples from dogs of seven breeds. Thirteen SNPs were detected in canine cbr1. A 10-bp deletion in the 5'-untranslated region (5'-UTR) was found in specimens from the Labrador Retriever, Beagle, Siberian Husky, and Boxer breeds. The 5'-UTR also included a polymorphic "hot spot" region immediately downstream of the 10-bp deletion. DNA sequence variants in the "hot spot region" ranged from 1 to 21 bp in length. Bioinformatics searches identified a cluster of three to six potential binding sites for the transcription factor Sp1 in the DNA segment containing both the "hot spot" region and the 10-bp deletion. This information provides a foundation to allow us to investigate whether DNA sequence variants in the 5'-UTR of canine cbr1 impact the pharmacodynamics of anticancer anthracyclines in dogs.
INTRODUCTION
The anticancer anthracyclines doxorubicin and daunorubicin are used to treat a variety of cancers in dogs including lymphomas, hemangiosarcoma, osteosarcoma, mammary tumors, and squamous cell carcinomas (Simon et al., 2006) . The therapeutic utility of anthracyclines is limited by the development of cardiotoxicity in some animals. The average incidence of anthracycline-related cardiotoxicity in dogs is ≈18%, and cardiotoxicity has been documented in up to 69% of animals (Gillings et al., 2009) . Anthracycline-related cardiotoxicity may induce sudden death by arrhythmias, or it may culminate in congestive heart failure (Herman et al., 1983; Herman and Ferrans, 1998; Morrison, 2002; Astra et al., 2003) . To the best of our knowledge, body weight is the only documented potential risk factor for anthracycline-related cardiotoxicity in dogs (Gillings et al., 2009) . Additional risk factors for anthracycline-related cardiotoxicity in dogs remain to be defined.
The pathogenesis of anthracycline-related cardiotoxicity is mediated by a combination of oxidative stress and metabolic perturbations induced by C-13 anthracycline alcohol metabolites (e.g., doxorubicinol and daunorubicinol) (Minotti et al., 2004) . Carbonyl reductase 1 (CBR1) catalyzes the synthesis of cardiotoxic C-13 alcohol metabolites. The role of CBR1 activity during the pathogenesis of anthracycline-related cardiotoxicity has been firmly established through biochemical and genetic studies in mice, humans and rabbits (Forrest et al., 2000; Mordente et al., 2001; Olson et al., 2003) . Interestingly, single nucleotide polymorphisms (SNPs) in the human CBRs impact the pharmacodynamics of anthracyclines and the risk of anthracycline-related cardiotoxicity (Lal et al., 2008; Blanco et al., 2008 Blanco et al., , 2011 . We hypothesize that SNPs in canine cbr1 may contribute to the variable pharmacodynamics of anthracyclines in dogs. Here, we documented DNA sequence variants in canine cbr1 by analyzing DNA samples from dogs of 7 breeds. Foundation for Animals, OFFA). DNA was isolated from peripheral blood using standard methodology.
DNA samples

Detection of cbr1 polymorphisms
Canine cbr1 exons 1, 2, 3 and corresponding flanking sequences (Canis lupus familiaris, chromosome 31, GenBank reference sequence NC_006613.2) were amplified by polymerase chain reaction (Appendix 1). Amplification products were sequenced with forward and reverse primers in an Applied Biosystems 3130xl Genetic Analyzer. SNP analysis was performed with a web-based tool (http://lpgws.nci.nih.gov/perl/snp/snp_cgi.pl). The presence of SNPs, nucleotide insertions and nucleotide deletions was verified by visual inspection of the electropherograms.
RESULTS AND DISCUSSION
The 3 exons of canine cbr1 and up to 359 bp from the 5'-untranslated region (5'-UTR) were amplified to analyze the presence of DNA sequence variants in the coding and potential promoter regions, respectively. Thirteen SNPs were detected in canine cbr1, including 2 synonymous SNPs, 7 SNPs in the 5'-UTR and 4 intronic SNPs (Tables 1 and 2) . A 10-bp deletion in the 5'-UTR was present in specimens from the Labrador Retriever, Beagle, Siberian Husky, and Boxer breeds. The 5'-UTR included a polymorphic "hot spot" region immediately downstream of the 10-bp deletion. The "hot spot" included sequence variants ranging from 1 to 21 bp in length. None of the 61 DNA samples (including 11 samples from Boxer dogs) showed the corresponding 10-bp fragment (5'-CACGAGACCC-3') reported in the GenBank reference sequence from a Boxer dog (Table 1) . These findings highlight the polymorphic nature of the dog's genome.
Bioinformatics searches focused on the proximal 5'-UTR of canine cbr1 (400 bp screened) pinpointed a cluster of 3 to 6 conserved motifs for the transcription factor Sp1 (5'-GCCACGCC-3') (McDowell et al., 2005) . The number of Sp1 motifs, 10-bp deletion status (yes/no), and corresponding DNA sequences for the "hot spot" region are listed in Table 3 . Of note, the Sp1 cluster is located in the DNA segment containing both the "hot spot" region and the polymorphic 10-bp deletion (length: 44 to 64 bp). In this segment, the GenBank reference sequence has a total of 4 Sp1 motifs (Table 3) . Interestingly, one Sp1 motif is abrogated by the 10-bp deletion. In contrast, the presence of "hot spot" variants 3, 5, 7, and 9 resulted in an additional Sp1 motif. Similarly, 2 additional Sp1 motifs were created when the relatively long "hot spot" variant 8 (length: 21 bp) was present (Tables 1 and  3 ). Our previous studies have shown that the aryl hydrocarbon receptor pathway regulates the expression of human CBR1 through conserved xenobiotic response elements (XREs) in the gene promoter region (Lakhman et al., 2007) . Here, we pinpointed a conserved XRE (5'-CACGCCA-3') in the vicinity of the Sp1 cluster in the 5'-UTR of canine cbr1 (306 bp upstream of the translation initiation codon, A +1 TG). Future studies are warranted to investigate whether the XRE, in concert with the variable number of Sp1 motifs, impacts the transcription of canine cbr1 and, consequently, the pharmacodynamics of anticancer anthracyclines in dogs (Wang et al., 1998) . In some cases, the number of samples analyzed was different from the totals shown in the first column. p and q = allele frequencies. Table 3 . Number of Sp1 motifs, 10-bp deletion status (yes/no), and corresponding DNA sequences for the "hot spot" region in the 5'-UTR of canine cbr1.
